The PCC and the Big Three: Breath, Plasma, and IRMS Steroidome
A nonprofit launched in 2008, the Partnership for Clean Competition (PCC) is committed to advancing high-quality anti-doping research and development. The PCC, which empowers independent research by experts across a variety of scientific disciplines, is the result of a collaboration between the U.S. Olympic Committee, the U.S. Anti-Doping Agency, the National Football League, and Major League Baseball. These organizations were later joined by the National Hockey League and the PGA TOUR.
In 2017, the PCC launched the Translational Research Fund (TRF) to facilitate the adoption of PCC-supported developments at anti-doping laboratories worldwide. Through the TRF, the PCC has invested in three projects that have the potential to significantly impact anti-doping testing and analysis in order to improve both detection and deterrence of performance-enhancing drugs. While still under development, these innovations could benefit athletes and anti-doping efforts worldwide in the months and years to come.
Here is what you need to know about the PCC’s big three:
For more information about the PCC and its projects, visit: www.cleancompetition.org.